Breaking Down Revenue Trends: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.

Comparing Revenue Growth: Perrigo vs. Arrowhead

__timestamp	Arrowhead Pharmaceuticals, Inc.	Perrigo Company plc
Wednesday, January 1, 2014	175000	4060800000
Thursday, January 1, 2015	382000	4603900000
Friday, January 1, 2016	158333	5280600000
Sunday, January 1, 2017	31407709	4946200000
Monday, January 1, 2018	16142321	4731700000
Tuesday, January 1, 2019	168795577	4837400000
Wednesday, January 1, 2020	87992066	5063300000
Friday, January 1, 2021	138287000	4138700000
Saturday, January 1, 2022	243231000	4451600000
Sunday, January 1, 2023	240735000	4655600000
Monday, January 1, 2024	3551000

Unlocking the unknown

Revenue Trends: A Tale of Two Companies

In the ever-evolving landscape of pharmaceuticals, understanding revenue trends is crucial. Perrigo Company plc and Arrowhead Pharmaceuticals, Inc. offer a fascinating study in contrasts. Over the past decade, Perrigo has consistently maintained a robust revenue stream, peaking in 2016 with a 30% increase from 2014. However, recent years have seen a slight decline, with 2021 marking a 20% drop from its peak.

Arrowhead Pharmaceuticals, on the other hand, has shown a remarkable growth trajectory. From a modest start in 2014, its revenue surged by over 1,300% by 2022, reflecting its dynamic expansion in the biotech sector. Despite a slight dip in 2023, Arrowhead's growth story remains compelling.

This data highlights the contrasting strategies and market positions of these two companies, offering valuable insights for investors and industry watchers alike.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025